Clarifying the Risk of Lung Disease in SZ α1-antitrypsin Deficiency AN Franciosi, BD Hobbs, OJ McElvaney, K Molloy, C Hersh, L Clarke, ... American Journal of Respiratory and Critical Care Medicine, 2020 | 43 | 2020 |
Alpha-1 antitrypsin deficiency–associated panniculitis AN Franciosi, J Ralph, NJ O'Farrell, C Buckley, C Gulmann, M O'Kane, ... Journal of the American Academy of Dermatology 87 (4), 825-832, 2022 | 35 | 2022 |
Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians AN Franciosi, TP Carroll, NG McElvaney The Lancet Respiratory Medicine 7 (12), 1059-1067, 2019 | 33 | 2019 |
Consequences of Abrupt Cessation of Alpha1-Antitrypsin Replacement Therapy OJ McElvaney, TP Carroll, AN Franciosi, J Sweeney, BD Hobbs, ... New England Journal of Medicine 382 (15), 1478-1480, 2020 | 31 | 2020 |
Nanoparticle Biomolecular Corona-Based Enrichment of Plasma Glycoproteins for N-Glycan Profiling and Application in Biomarker Discovery DN Trinh, RA Gardner, AN Franciosi, C McCarthy, MP Keane, ... ACS nano 16 (4), 5463-5475, 2022 | 22 | 2022 |
SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ AN Franciosi, TP Carroll, NG McElvaney Thorax 76 (3), 298-301, 2021 | 22 | 2021 |
Alpha-1 Antitrypsin Deficiency and Tobacco Smoking: Exploring Risk Factors and Smoking Cessation in a Registry Population AN Franciosi, MA Alkhunaizi, A Woodsmith, L Aldaihani, H Alkandari, ... COPD: Journal of Chronic Obstructive Pulmonary Disease 18 (1), 76-82, 2020 | 22 | 2020 |
Unusual acute sequelae of α1-antitrypsin deficiency: a myriad of symptoms with one common cure AN Franciosiz, C McCarthy, TP Carroll, NG McElvaney Chest 148 (5), e136-e138, 2015 | 19 | 2015 |
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema AN Franciosi, C McCarthy, NG McElvaney Expert review of respiratory medicine 9 (2), 143-151, 2015 | 19 | 2015 |
Alpha-1 antitrypsin deficiency: clarifying the role of the putative protective threshold AN Franciosi, D Fraughen, TP Carroll, NG McElvaney European Respiratory Journal 59 (2), 2022 | 17 | 2022 |
Pulmonary alveolar proteinosis OJ McElvaney, D Horan, AN Franciosi, C Gunaratnam, NG McElvaney QJM: An International Journal of Medicine 111 (3), 185-186, 2018 | 12 | 2018 |
Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis MD Prieto, ME Alam, AN Franciosi, BS Quon ERJ Open Research 9 (1), 2023 | 11 | 2023 |
Acute pulmonary exacerbation phenotypes in patients with cystic fibrosis SC Carter, AN Franciosi, KM O’Shea, OM O’Carroll, A Sharma, A Bell, ... Annals of the American Thoracic Society 19 (11), 1818-1826, 2022 | 11 | 2022 |
The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis JT Song, S Desai, AN Franciosi, RVE Dagenais, BS Quon Journal of cystic fibrosis: official journal of the European Cystic Fibrosis …, 2022 | 10 | 2022 |
Cystic fibrosis respiratory microbiology monitoring during a global pandemic: lessons learned from a shift to telehealth AN Franciosi, PG Wilcox, BS Quon Annals of the American Thoracic Society 19 (3), 498-500, 2022 | 10 | 2022 |
Assessing potential risks of treatment with long-term azithromycin in COPD patients: long-term oxygen users beware? TT Nicholson, A Franciosi, S Landers, MW Butler Irish Journal of Medical Science (1971-) 185, 993-997, 2016 | 9 | 2016 |
Factors affecting prognosis and prediction of outcome in cystic fibrosis lung disease C McCarthy, O O’Carroll, AN Franciosi, NG McElvaney Cystic fibrosis in the light of new research, 2015 | 9 | 2015 |
TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary) AN Franciosi, BS Quon Journal of Cystic Fibrosis 20, 55-56, 2021 | 8 | 2021 |
Risk factors for totally implantable venous access device-associated complications in cystic fibrosis C McCarthy, O O’Carroll, ME O’Brien, T McEnery, A Franciosi, ... Irish Journal of Medical Science (1971-) 187, 429-434, 2018 | 6 | 2018 |
Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CTPFAV) in idiopathic pulmonary fibrosis M O'Callaghan, J Duignan, EJ Tarling, DK Waters, M McStay, O O'Carroll, ... Respirology 28 (11), 1043-1052, 2023 | 5 | 2023 |